In conclusion, the ammonia oxidizing bacteria N. eutropha D23 shows promising therapeutic potential to target atopic diseases due to its ability to block Th2 polarization and key cytokines involved in IgE production, eosinophilia, and itch. The gene discussed is IGHE; the disease is Increased total eosinophil count.